ClearBridge Investments’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,187,491
Closed -$4.25M 1105
2019
Q3
$4.25M Sell
1,187,491
-112,220
-9% -$435K ﹤0.01% 596
2019
Q2
$5.19M Buy
1,299,711
+138,373
+12% +$802K ﹤0.01% 573
2019
Q1
$8.49M Buy
1,161,338
+38,400
+3% +$375K 0.01% 544
2018
Q4
$10.3M Buy
1,122,938
+218,805
+24% +$2.42M 0.01% 521
2018
Q3
$11.2M Buy
904,133
+904,057
+1,189,549% +$12.2M 0.01% 531
2018
Q2
$1K Buy
76
+10
+15% +$173 ﹤0.01% 1124
2018
Q1
$1K Buy
66
+9
+16% +$155 ﹤0.01% 1127
2017
Q4
$1K Buy
+57
New +$1.14K ﹤0.01% 1140

Other funds holding DVAX

ClearBridge Investments's DVAX Position: Q4 2019 in Review

ClearBridge Investments sold out of Dynavax Technologies (DVAX) in Q4 2019, closing a stake of 1,187,491 shares — an estimated $4.25M sold.

ClearBridge Investments first reported a position in DVAX in Q4 2017 and held it in 8 quarters. The position peaked at $11.2M in Q3 2018. 123 funds tracked by Wall St. Rank hold DVAX as of Q4 2019.

  • ClearBridge Investments reported no remaining Dynavax Technologies position as of Q4 2019 after selling out during the quarter.
  • ClearBridge Investments sold 1,187,491 Dynavax Technologies shares in Q4 2019, an estimated $4.25M.
  • ClearBridge Investments first reported a position in Dynavax Technologies in Q4 2017 and held it in 8 quarters.
  • ClearBridge Investments's Dynavax Technologies position peaked at $11.2M in Q3 2018.
  • 123 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2019.

Based on ClearBridge Investments's 13F filing for Q4 2019, filed 14 Feb 2020.